porphobilinogen has been researched along with Liver Diseases in 34 studies
Liver Diseases: Pathological processes of the LIVER.
Excerpt | Relevance | Reference |
---|---|---|
"Griseofulvin(GF) has become the drug of choice as an antifungal agent for patients who suffer from many kinds of fungal infection." | 5.28 | Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin. ( Cho, HM; Choi, SW; Chung, KW; Han, JH; Kim, BS; Lim, KT; Park, DH; Seo, EJ; Sun, HS, 1991) |
"Clonazepam was ineffective in treating the seizures and, in high doses, seemed to exacerbate the porphyria." | 5.26 | Seizure management in acute hepatic porphyria: risks of valproate and clonazepam. ( Bonkowsky, HL; Emery, S; Sinclair, JF; Sinclair, PR, 1980) |
"Griseofulvin(GF) has become the drug of choice as an antifungal agent for patients who suffer from many kinds of fungal infection." | 1.28 | Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin. ( Cho, HM; Choi, SW; Chung, KW; Han, JH; Kim, BS; Lim, KT; Park, DH; Seo, EJ; Sun, HS, 1991) |
"The porphyrias are caused by hereditary defects in the synthesis of heme." | 1.27 | The porphyrias. ( Rosen, T; Sekula, SA; Tschen, JA, 1986) |
"Clonazepam was ineffective in treating the seizures and, in high doses, seemed to exacerbate the porphyria." | 1.26 | Seizure management in acute hepatic porphyria: risks of valproate and clonazepam. ( Bonkowsky, HL; Emery, S; Sinclair, JF; Sinclair, PR, 1980) |
"Antipyrine T1/2 was especially prolonged in patients with a history of more severe symptoms, but there was no correlation with the degree of elevation in urinary excretion of the porphyrin precursors delta-aminolevulinic acid (ALA) and porphobilinogen (PBG)." | 1.26 | Studies in porphyria. V. Drug oxidation rates in hereditary hepatic porphyria. ( Alvares, AP; Anderson, KE; Kappas, A; Sassa, S, 1976) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 32 (94.12) | 18.7374 |
1990's | 2 (5.88) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
MIHAI, C | 1 |
HULUBEI, P | 1 |
OANCEA, C | 1 |
Ibraham, NG | 1 |
Friedland, ML | 1 |
Levere, RD | 1 |
Knosała, P | 1 |
Petelenz, T | 1 |
Zuk-Popiołek, I | 1 |
Bonkowsky, HL | 2 |
Schady, W | 1 |
Pathak, MA | 1 |
West, JD | 1 |
Sinclair, PR | 1 |
Emery, S | 1 |
Sinclair, JF | 1 |
Laiwah, AC | 1 |
Goldberg, A | 4 |
Moore, MR | 4 |
Romeo, G | 1 |
Waldenström, J | 1 |
McColl, KE | 3 |
Wallace, AM | 2 |
Thompson, GG | 2 |
Day, RS | 1 |
Eales, L | 1 |
Loftin, EB | 1 |
Adam, C | 1 |
Hassoun, A | 1 |
Defresne, C | 1 |
Guilmot-Bruneau, M | 1 |
Wery-Follet, B | 1 |
Saussez-De Temmerman, A | 1 |
Doss, M | 4 |
von Tiepermann, R | 1 |
Schneider, J | 1 |
Becker, DM | 1 |
Kramer, S | 1 |
Walsh, JR | 1 |
Stolle, D | 1 |
Strohmeyer, G | 1 |
Anderson, KE | 1 |
Alvares, AP | 1 |
Sassa, S | 1 |
Kappas, A | 2 |
Choi, SW | 1 |
Han, JH | 1 |
Lim, KT | 1 |
Cho, HM | 1 |
Chung, KW | 1 |
Sun, HS | 1 |
Park, DH | 1 |
Kim, BS | 1 |
Seo, EJ | 1 |
Herrick, AL | 1 |
Doss, MO | 1 |
Frank, M | 1 |
Bissell, DM | 1 |
Wehmeier, A | 1 |
Fischer, JT | 1 |
Goerz, G | 1 |
Schneider, W | 1 |
Sekula, SA | 1 |
Tschen, JA | 1 |
Rosen, T | 1 |
Birnie, GG | 1 |
Brodie, MJ | 1 |
Sixel-Dietrich, F | 2 |
Verspohl, F | 2 |
Galbraith, RA | 1 |
Drummond, GS | 1 |
Pfändler, U | 1 |
Haeger-Aronsen, B | 1 |
Abdulla, M | 1 |
Elder, GH | 1 |
8 reviews available for porphobilinogen and Liver Diseases
Article | Year |
---|---|
Heme metabolism in erythroid and hepatic cells.
Topics: 5-Aminolevulinate Synthetase; Aminolevulinic Acid; Coproporphyrinogen Oxidase; Erythrocytes; Erythro | 1983 |
Neurologic manifestations of acute porphyria.
Topics: Acute Disease; Aminolevulinic Acid; Animals; Central Nervous System; Depression; Electrophysiology; | 1982 |
Porphyrias: office procedures and laboratory tests for diagnosis of porphyrin abnormalities.
Topics: Chromatography, High Pressure Liquid; Chromatography, Paper; Clinical Enzyme Tests; Feces; Humans; I | 1982 |
The hepatic porphyrias.
Topics: 5-Aminolevulinate Synthetase; Acute Disease; Adolescent; Adult; Aminolevulinic Acid; Chemical Phenom | 1980 |
The porphyrias--a review.
Topics: Acute Disease; Aged; Alcoholism; Aminolevulinic Acid; Feces; Female; Heme; Humans; Iron; Liver Disea | 1981 |
The neurological manifestations of porphyria: a review.
Topics: Acute Disease; Aminolevulinic Acid; Animals; Heme; Humans; Liver; Liver Diseases; Nervous System; Ne | 1977 |
Hepatic porphyrias. Current concepts.
Topics: 5-Aminolevulinate Synthetase; Acute Disease; Coproporphyrinogens; Female; Genetic Diseases, Inborn; | 1977 |
[Pathobiochemistry of porphyrias].
Topics: Acute Disease; Aminolevulinic Acid; Catalase; Chronic Disease; Cytochrome P-450 Enzyme System; Heme; | 1977 |
26 other studies available for porphobilinogen and Liver Diseases
Article | Year |
---|---|
[Clinical value of urinary pentdyopent and porphobilinogen in patients with hepatic and renal diseases].
Topics: Hemoglobins; Humans; Kidney Diseases; Liver Diseases; Porphobilinogen; Porphyrins; Pyrroles | 1963 |
[A case of acute hepatic porphyria].
Topics: Acute Disease; Adult; Aminolevulinic Acid; Coproporphyrins; Humans; Liver Diseases; Male; Porphobili | 1983 |
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
Topics: 5-Aminolevulinate Synthetase; Adult; Aminolevulinic Acid; Animals; Benzodiazepinones; Chick Embryo; | 1980 |
Pathogenesis and treatment of acute intermittent porphyria: discussion paper.
Topics: Acute Disease; Aminolevulinic Acid; Blood-Brain Barrier; Heme; Humans; Liver Diseases; Porphobilinog | 1983 |
Alterations in haem biosynthesis during the human menstrual cycle: studies in normal subjects and patients with latent and active acute intermittent porphyria.
Topics: 5-Aminolevulinate Synthetase; Adrenal Cortex Hormones; Adult; Aminolevulinic Acid; Erythrocytes; Fem | 1982 |
Acute intermittent porphyria.
Topics: Acute Disease; Aminolevulinic Acid; Humans; Levulinic Acids; Liver Diseases; Porphobilinogen; Porphy | 1982 |
Hepatic porphyrias simulating typhoidal tularemia.
Topics: Adult; Diagnosis, Differential; Female; Humans; Liver Diseases; Porphobilinogen; Porphyrias; Tularem | 1982 |
[Hemin treatment in a case of porphyria variegata].
Topics: Adult; Aminolevulinic Acid; Coproporphyrins; Female; Heme; Hemin; Humans; Liver Diseases; Porphobili | 1982 |
Acute hepatic porphyria syndrome with porphobilinogen synthase defect.
Topics: Acute Disease; Adult; Amino Acids; Aminolevulinic Acid; Erythrocytes; Feces; Female; Humans; Lead; L | 1980 |
[Screening and rapid tests in liver and bile tract diseases].
Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Biliary Tract Diseases; Bil | 1976 |
Studies in porphyria. V. Drug oxidation rates in hereditary hepatic porphyria.
Topics: Adult; Aminolevulinic Acid; Antipyrine; Erythrocytes; Female; Half-Life; Humans; Hydroxymethylbilane | 1976 |
Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Bilirubin; Chemical and Drug Induced Liver Inju | 1991 |
Elevation of hormone-binding globulins in acute intermittent porphyria.
Topics: Adolescent; Adult; Aminolevulinic Acid; Arginine; Carrier Proteins; Heme; Humans; Hydrocortisone; Li | 1990 |
Hepatobiliary implications and complications in protoporphyria, a 20-year study.
Topics: Adult; Aminolevulinic Acid; Child, Preschool; Chromatography, Ion Exchange; Chromatography, Thin Lay | 1989 |
Latent acute hepatic porphyria.
Topics: Acute Disease; Heterozygote; Humans; Liver Diseases; Porphobilinogen; Porphyrias | 1985 |
Treatment of acute hepatic porphyria with hematin.
Topics: Acute Disease; Adult; Aged; Aminolevulinic Acid; Female; Heme; Hemin; Humans; Liver Diseases; Male; | 1988 |
Polychemotherapy of acute myelogenous leukemia in a patient with acute intermittent porphyria.
Topics: Acute Disease; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Chemical | 1987 |
The porphyrias.
Topics: Adolescent; Adult; Aminolevulinic Acid; beta Carotene; Bloodletting; Carotenoids; Child; Child, Pres | 1986 |
Antipyrine metabolism in acute hepatic porphyria in relapse and remission.
Topics: 5-Aminolevulinate Synthetase; Adolescent; Adult; Aged; Aminolevulinic Acid; Antipyrine; Cytochrome P | 1987 |
Hyperinsulinemia in acute intermittent porphyria.
Topics: Acute Disease; Adolescent; Adult; Aminolevulinic Acid; Female; Glucose Tolerance Test; Humans; Hyper | 1985 |
"Glucose effect" and rate limiting function of uroporphyrinogen synthase on porphyrin metabolism in hepatocyte culture: relationship with human acute hepatic porphyrias.
Topics: 5-Aminolevulinate Synthetase; Aminolevulinic Acid; Ammonia-Lyases; Animals; Cells, Cultured; Chick E | 1985 |
Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications.
Topics: 5-Aminolevulinate Synthetase; Allylisopropylacetamide; Animals; Chemical and Drug Induced Liver Inju | 1985 |
Enzymes in the hepatic porphyrias.
Topics: 5-Aminolevulinate Synthetase; Erythrocytes; Humans; Liver; Liver Diseases; Porphobilinogen; Porphyri | 1972 |
[Genetic prognosis of a mother with acute intermittent porphyria (hepatic form)].
Topics: Acute Disease; Adolescent; Adult; Aminolevulinic Acid; Female; Genes, Dominant; Genetic Counseling; | 1974 |
Evaluation of two methods for measuring delta-aminolaevulinic acid in urine. II. The influence of some Ehrlich-positive' substances on the measurements.
Topics: Adolescent; Adult; Aminosalicylic Acids; Bacteriuria; Child; Evaluation Studies as Topic; Female; Hu | 1972 |
The porphyrin excretion pattern of symptomatic porphyria.
Topics: Chemical Phenomena; Chemistry; Chromatography, Thin Layer; Feces; Female; Humans; Liver Diseases; Ma | 1971 |